The challenge of HIV-1 genetic diversity: Discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 5, 2009, Pages 659-661

  Bolivar, Hector ^a   Geffin, Rebeca ^a   Manzi, Gabriel ^b   Fischl, Margaret A ^a   Holzmayer, Vera ^c   Mak, Wai Bing ^c   Abravaya, Klara ^c   Hackett, John ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

^c Abbott Molecular Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; LETTER; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIROTHERAPY; VIRUS LOAD; VIRUS STRAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC VARIATION; HIV-1; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 73349141427     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b72539     Document Type: Letter

References (10)

1. Hemelaar J, Gouws E, Ghys PD, et al. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20:W13-W23.
2. Lin HH, Gaschen BK, Collie M, et al. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J Acquir Immune Defic Syndr. 2006;41:399-404.
3. Wheeler W, Mahle K, Bodnar U, et al. Anti-retroviral drug resistance mutations and subtypes in drug naive persons newly diagnosed with HIV-1 infection, United States, March 2003 to October 2006. Paper presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 25-28, 2007; Los Angeles, CA.
4. Damond F, Roquebert B, Bénard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/ COBAS TaqMan HIV-1 assays. J Clin Micro-biol. 2007;45:3436-3438.
5. Gueudin M, Plantier JC, Lemée V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007;44:500-505.
6. Swanson P, de Mendoza C, Joshi Y, et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol. 2005; 43:3860-3868.
7. von Truchsess I, Harris B, Schätzl HM, et al. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays. J Med Virol. 2006;78: 311-317.
8. Teixeira SL, Bastos FI, Telles PR, et al. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity. J Clin Virol. 2004;31:221-226.
9. Schmidt M, Korn K, Nübling CM, et al. First transmission of human immunodeficiency virus type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 2009;49:1836-1844.
10. Geelen S, Lange J, Borleffs J, et al. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. AIDS. 2003; 17:781-782.